Comparison of baseline quality of life measures between renal cell carcinoma patients undergoing partial versus radical nephrectomy by unknown
Arnold et al. BMC Urology 2013, 13:52
http://www.biomedcentral.com/1471-2490/13/52RESEARCH ARTICLE Open AccessComparison of baseline quality of life measures
between renal cell carcinoma patients
undergoing partial versus radical nephrectomy
Michelle L Arnold1, David D Thiel2, Nancy Diehl1, Kevin J Wu3, Steve Ames4 and Alexander S Parker1*Abstract
Background: To compare demographics, pathologic features, performance scores, comorbidities, symptoms and
responses to quality of life (QoL) surveys between nephron-sparing surgery (NSS) and radical nephrectomy (RN)
patients prior to surgical intervention. Previous investigators have compared QoL outcomes for patients undergoing
RN and NSS; however, there are limited data comparing QoL-related characteristics at baseline between these
groups.
Methods: We identified 144 patients with localized RCC who underwent either NSS (n = 71) or RN (n = 73) between
May ‘07-November ‘12. We abstracted baseline data on demographic and clinic-pathologic variables as well as
responses to the SF-36 and FACT-G surveys from our prospective registry. We amended the FACT-G with 8
additional questions designed to address RCC-specific QoL. For comparisons between the two groups, we
employed Wilcoxon rank-sum and Fisher's Exact tests where appropriate.
Results: We observed RN patients to have more aggressive pathology. We noted no difference in performance
scores between the two groups; however, RN patients were more likely to have higher Charlson scores (p = 0.022)
and various symptoms at presentation (all p <0.001). For the QoL surveys, we did not observe differences on the
FACT-G; however, we noted evidence of differential scores between the two groups on specific domains of the
SF-36 (e.g. Mental Health; p 0.022) and the RCC-specific QoL questions added to the FACT-G.
Conclusions: We report baseline differences between RN and NSS patients on clinico-pathologic as well as
QoL-related metrics. As issues of survivorship become increasingly important, our results underscore the need to
consider baseline status in evaluations of QoL-related outcomes for patients undergoing surgery for RCC.
Keywords: Kidney cancer, Quality of life, Radical nephrectomy, Nephron-sparing surgeryBackground
The standard treatment for localized, unilateral renal cell
carcinoma (RCC) is surgical excision. Related to this,
while radical nephrectomy (RN) remains the best option
for many RCC patients, nephron-sparing surgery (NSS)
has evolved over the past two decades into the standard
treatment for patients presenting with pT1a RCC and
its use is increasing for pT1b and pT2 RCC patients
as well [1,2]. The emergence of NSS as a viable means of
maintaining cancer control for patients with localized* Correspondence: parker.alexander@mayo.edu
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reproduction in any medium, provided the orRCC has generated interest in the broader question of
whether NSS and RN have similar effects on the post-
surgical quality of life (QoL). In an age where RCC inci-
dence is rising [3] and issues of cancer survivorship have
become germane, a better understanding of the effect of
NSS compared to RN on standard QoL metrics has the
potential to further inform the shared decision-making
process for surgeons and patients faced with surgical man-
agement options for clinically localized RCC.
To date, a handful of investigators have addressed the
question of QoL outcomes in RCC patients [4-10]; how-
ever only three have directly addressed the direct compari-
son of QoL measures between patients undergoing NSS
and RN [5,6,8]. Interestingly, while one study reported noLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gical groups [5], two of the studies presented evidence
suggesting improved QoL outcomes for the NSS versus
RN group [6,8]. A key limitation in each of these investiga-
tions is the absence of information on baseline measures
of QoL prior to surgery. More recently Parker et al. [10]
advanced the field with their report from the largest and
most definitive observational study to date on the issue of
QoL outcomes across four common surgical interven-
tions. In contrast to previous studies, the authors de-
scribed their access to baseline QoL measures prior to
surgical intervention; however, they did not present these
baseline data for review and did not adjust for baseline
status in their analyses, citing only a lack of statistically
significant difference between the groups at baseline.
Moreover, the authors do not discuss baseline comparisons
on QoL-related metrics such as presence of comorbidities,
performance score or symptomatic presentation. As such,
a simple yet important question that remains unclear is
whether RCC patients undergoing NSS and RN have simi-
lar baseline levels of QoL and other related metrics prior
to surgical intervention.
Motivated by this continuing gap in our knowledge,
we explore for the first time whether patients who
undergo NSS and those that undergo RN have similar
QoL status at baseline. Specifically, we hypothesize that
there are key differences between RN and NSS patients
at baseline and as such, these should be taken in to ac-
count when comparing follow-up outcomes between
these two groups. To test this hypothesis, we compare
baseline demographics, pathologic features, comorbidity
scores, performance status and responses to the SF-36
Health Survey (SF-36) and Functional Assessment of
Cancer Therapy-General (FACT-G) questionnaires be-




A valuable prerequisite for evaluating issues related to
RCC survivorship is the availability of a large, compre-
hensively annotated database of patients undergoing
curative surgical therapy for RCC. Related to this, we
maintain a prospective Nephrectomy Registry database
of all patients undergoing treatment for RCC at our
institution.
Briefly, certified clinical coordinators consent and en-
roll patients to the Registry during the patient’s pre-
operative visit. After consent, the coordinators abstract
over three hundred clinical variables from each patient’s
medical record including demographic data, diagnosis
date, inheritable syndromes, signs and symptoms, results
of laboratory and imaging tests, performance status,
surgical characteristics and surgical complications. Inaddition, the coordinators provide self-administered
questionnaires to each enrolled patient at the time of
enrollment to collect valuable lifestyle and risk factor
data including smoking history, weight history,
physician-diagnosed UTI and family history of cancer.
Moreover, a urologic pathologist conducts a compre-
hensive, centralized review of all nephrectomy speci-
mens to confirm several important prognostic features
including histological subtype using the contemporary
1997 AJCC/UICC classification, tumor stage, nuclear
grade, tumor size, and coagulative tumor necrosis. Most
germane to this investigation, in 2007 the coordinators
began requesting that all participants complete the modi-
fied FACT-G and the SF-36 QoL measures prior to sur-
gery to establish a baseline measure of patient QoL
metrics. This Registry effort provides the data on the tar-
get population of patients undergoing RN and NSS for
our investigation. Of note, while over 95% of all patients
who undergo surgical treatment for localized RCC at our
institution consent to participate in our Registry, our re-
sponse rate for the QoL questionnaire is approximately
49%. Interestingly, we note that responders tend to be
slightly younger, have a higher body mass index, and have
a better performance status as measure by the ECOG and
Karnofsky measures when compared to non-responders
(all p-values <0.05). In contrast, we noted no meaningful
differences between responders and non-responders with
regard to gender, education level, and race/ethnicity.
Patient selection
Following approval by the Mayo Clinic Institutional
Review Board (#610-05), we queried the Nephrectomy
Registry and identified 144 patients treated with RN or
NSS for unilateral, sporadic, RCC at our institution be-
tween May 2007 and November 2012 who completed
both the SF-36 and FACT-G prior to their surgery.
Clinical and pathologic features
We abstracted data from our Registry database on the
following clinical variables: age at surgery, sex, comor-
bidity at presentation, ECOG and Karnofsky perform-
ance status, tumor thrombus level and Charlson score
[11]. Patients with any component of the Charlson score,
which includes history of myocardial infarction, congestive
heart failure, peripheral vascular disease, cerebrovascular
disease, dementia, chronic pulmonary disease, connective
tissue disease, ulcer disease, mild liver disease, diabetes,
hemiplegia, moderate or severe renal disease, diabetes
with end organ damage, any previous tumor, leukemia,
lymphoma, moderate or severe liver disease, any previous
metastatic solid tumor, or AIDS were considered to have
comorbid disease. In addition, we also abstracted data on
the following pathologic features: tumor size, 2002 pri-
mary tumor classification, the 2002 TNM stage groupings,






Age at diagnosis (years) 0.283
< 65 36 (51%) 34 (47%)
≥ 65 35 (49%) 39 (53%)
Male 45 (63%) 51 (70%) 0.482
Race - white 65 (92%) 64 (88%) 0.592
Marital Status 1.002
Married 55 (77%) 57 (78%)
Widowed, Divorced, Single 16 (23%) 16 (22%)
Education 0.112
HS Graduate/GED 8 (11%) 15 (21%)
1-3 Vocational/Some College 30 (42%) 20 (27%)
College Graduate/Graduate School 29 (41%) 29 (40%)
Other/Unknown 4 (6%) 9 (12%)
BMI 0.0723
< 30 35 (49%) 43 (59%)
≥ 30 36 (51%) 30 (41%)
ECOG Performance Status n = 69 n = 72 0.762
0 – Fully active 64 (93%) 65 (90%)
1, 2 – Some restriction 5 (7%) 7 (10%)
Karnofsky Performance Status n = 62 n = 64 0.623
100 55 (89%) 55 (86%)
70 - 90 7 (11%) 9 (14%)
Histologic Subtype 0.852
Clear cell 46 (65%) 49 (67%)
Papillary/Chromophobe/RCC 16 (23%) 17 (23%)
Oncocytoma/Angiomyolipoma/
Other benign
9 (13%) 7 (10%)
Nuclear grade n = 62 n = 66 0.0013
1-2 51 (82%) 40 (61%)
3-4 11 (18%) 26 (39%)
Charlson score 0.183
0 37 (52%) 35 (48%)
1-2 28 (39%) 21 (29%)
3-4 6 (8%) 11 (15%)
≥ 5 0 (0%) 6 (8%)
Tumor Stage n = 62 n = 65 <0.0012
pT1a/pT1b 59 (95%) 39 (60%)
pT2 1 (2%) 10 (15%)
pT3a/pT3b 2 (3%) 16 (25%)
1The sample median (minimum, 25th percentile, 75th percentile, maximum) is
given for numerical variables, n (%) for categorical variables.
2P-values result from Fisher’s exact test.
3P-values result from Wilcoxon rank sum test (although data is
presented categorically).
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Of note, as part of our Registry effort, a single urologic
pathologist (K.J.W.) completes a centralized review of all
pathology specimens to confirm histologic diagnosis and
provide robust pathologic metrics for our cases.
Quality of life measures
As mentioned above, all 144 patients completed both
the SF-36 Health Survey and the FACT-G questionnaire
prior to surgical treatment for localized RCC. The SF-36
Health survey comprises 36 questions to assess 8 do-
mains of functional health and well-being. The authors
of the survey designed it to be used independent of age,
disease, or treatment modality and as such it is widely
used to assess QoL status in both general and disease-
specific populations. All 36 questions on the SF-36 are
scored on a scale from 0 to 100, with 100 as the highest
level of functioning. Collective scores are calculated as a
percentage of the total points possible. The scores from
those questions that address each specific domain of
functional health status are averaged together, for a final
score with each of the 8 domains assessed. The FACT-G
is a 33-item questionnaire that is a validated tool for
assessing QoL associated with the management of
chronic illness [12]. The questionnaire measures four
specific QoL domains (physical, social, emotional, and
functional well-being) which each have individual scores
but are also summed to achieve a total score, with
higher scores indicating better QoL. For this study, we
used our experience from a previously published focus
group of surgically-treated RCC patients to augment the
FACT-G with eight additional questions designed to ad-
dress kidney-specific QoL issues [4]. Each question pre-
sents a statement and the patient indicates whether this
occurs “Not at All”, “A Little Bit”, “Somewhat”, “Quite a
Bit” or “Very Much”.
Statistical methods
For our analyses we summarized continuous data using
the sample median (minimum, 25th percentile, 75th per-
centile, maximum) and categorical data as counts and
percentages. For comparisons between our two surgical
groups involving the median of continuous variables we
employed Wilcoxon rank-sum tests and for comparisons
involving percentages of categorical variables we utilized
Fisher's Exact test. All statistical tests were two-sided,
and the threshold of significance was set at p = 0.05.
Results
A total of 144 patients were included in this study; 73
who underwent RN and 71 who underwent NSS. In
Table 1, we provide a comparison of patient and RCC
tumor characteristics between the two surgical groups.
For demographic and anthropometric indices, patients
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to age, gender, marital status, education level; however,
NSS patients were slightly more likely to be classified as
obese given the higher percentage with a BMI greater
than 30 kg/m2 (51% vs. 41% p = 0.07). Not surprisingly,
we noted key differences in pathologic features with RN
patients presenting with more aggressive tumors. Specif-
ically, RN were more likely to be larger in size (5 cm vs.
3 cm; p <0.001), be grade 3 or 4 (39% vs. 11%; p =0.001)
and classified as pT2 or later (40% vs. 5%; p <0.001). We
observed no difference in ECOG or Karnofsky perform-
ance status between the RN and NSS groups (p = 0.76
and 0.62, respectively). While a global test suggested lit-
tle evidence of an overall difference in Charlson score
between the two groups (p = 0.18), it is worth noting
that the percentage of patients with a Charlson score of
3 or more was notably higher in the RN compared to
the NSS group (23% vs. 8%; p = 0.022). In Table 2 we
provide a more detailed comparison of the patient symp-
toms at presentation for our two surgical groups. As
expected, the RN group were more likely to present with
several symptoms including discomfort on ipsilateralTable 2 Patient symptoms at presentation in patients







Palpable flank 2 (1%) 0 (0%) 2 (3%)
Abdominal mass 1 (1%) 0 (0%) 1 (1%)
Discomfort ipsilateral side 24 (17%) 8 (11%) 16 (22%)
Discomfort contralateral side 10 (7%) 2 (3%) 8 (11%)
Rash 1 (1%) 1 (1%) 0 (0%)
Sweats 5 (3%) 2 (3%) 3 (4%)
Weight loss 8 (6%) 1 (1%) 7 (10%)
Fatigue 7 (5%) 3 (4%) 4 (6%)
GI early satiety or decreased appetite 3 (2%) 0 (0%) 3 (4%)
Gross hematuria 13 (9%) 2 (3%) 11 (15%)
Microhematuria 17 (13%) 10 (15%) 7 (10%)
Acute onset varicocele 0 (0%) 0 (0%) 0 (0%)
Impaired renal function 20 (14%) 6 (8%) 14 (19%)
Hypertension of recent onset 0 (0%) 0 (0%) 0 (0%)
Polycythemia of recent onset 0 (0%) 0 (0%) 0 (0%)
Anemia of recent onset 0 (0%) 0 (0%) 0 (0%)
Number of pre-existing conditions
None 69 (48%) 44 (62%) 25 (35%)
1-2 69 (48%) 27 (38%) 42 (58%)
3+ 5 (3%) 0 (0%) 5 (7%)
1The n (%) is given for categorical variables.
2Information was unavailable for each symptom in a minimum of 1 patient to
a maximum of 2 patients except for microhematuria which was unavailable in
9 patients.side (22% vs. 11%; p = 0.12), weight loss (10% vs. 1%; p =
0.063), gross hematuria (15% vs. 3%; p = 0.017) and im-
paired renal function (19% vs. 8%; p = 0.09).
In Table 3 we display a comparison of the scores on
the SF-36 between our two surgical groups. Interestingly,
despite the aforementioned differences in pathologic fea-
tures and symptomatic presentation, NSS patients did
not report significantly higher median scores on the SF-
36 at baseline for the general health (72 vs. 67; p = 0.93)
and vitality (53 vs. 50; p = 0.91) domains. We did observe
evidence of considerably better median scores for NSS
patients on the role physical (75 vs. 50; p = 0.50) do-
main; however this differences did not achieve con-
ventional statistical significance. Interestingly, RN patients
reported significantly higher median scores (i.e. better
scores) on mental health (80 vs. 72; p = 0.023) domain.
We noted similar trends for better scores for RN patients
on the role emotional domain (100 vs. 67; p = 0.31) and
bodily pain (71 vs. 62; p = 0.72) domains; however despite
the large differences, the p-values could not rule out the
role of chance as an explanation. In Table 4, we display a
comparison of baseline scores on the FACT-G (which
more closely reflects disease-specific QoL). In contrast to
the evidence of differences on some domains of the SF-36,
we observed strikingly similar responses on the FACT-G
for the two surgical groups (i.e. all median scores within
two points between the groups). Finally, in Table 5 we
provide a comparison of the two groups across our add-
itional questions that were added to the FACT-G based
on results from the focus group [4]. Interestingly, we
noted that “I experience significant pain in certain areas of
my body” and “problems with pain limit my activities” was
identified as happening “quite a bit or very much” more
often in the NSS vs. the RN (29% vs. 22%; p = 0.42 and
20% vs. 10%, 0.18; respectively). As expected, our small
sample size coupled with the multi-category nature of the
responses to these statements (i.e. requiring more degreesTable 3 Patient Baseline SF-36 Index scores by treatment
type (NSS vs. RN)
Variable NSS1 (N = 71) RN1 (N = 73) p-value2
Physical Functioning 75 (5, 40, 95, 100) 75 (0, 50, 95, 100) 0.85
Bodily Pain 62 (0, 41, 88, 100) 71 (12, 41, 100, 100) 0.72
General Health 72 (10, 47, 82, 100) 67 (6.3, 52, 87, 100) 0.93
Mental Health 72 (20, 60, 84, 100) 80 (24, 64, 92, 100) 0.023
Role Emotional 67 (0, 0, 100, 100) 100 (0, 33, 100, 100) 0.31
Role Physical 75 (0, 0, 100, 100) 50 (0, 0, 100, 100) 0.50
Social
Functioning
75 (0, 50, 100, 100) 75 (0, 50, 100, 100) 0.83
Vitality 53 (0, 30, 70, 100) 50 (0, 30, 75, 100) 0.91
1The sample median (minimum, 25th percentile, 75th percentile, maximum)
is given.
2P-values result from Wilcoxon rank sum test comparing NSS to RN.
Table 4 Patient Baseline FACT-G Index scores by
treatment type (NSS vs. RN)
Variable NSS1 (N = 71) RN1 (N = 73) p-value2
Physical Well Being 25 (0, 20, 27, 28) 25 (5, 22, 27, 28) 0.90
Emotional Well Being 17 (5, 15, 19, 24) 18 (1, 14, 19, 24) 0.61
Social/Family Well
Being
25 (0, 21, 27, 28) 25 (9, 21, 28, 28) 0.71
Functional Well Being 21 (2.3, 16, 24, 28) 19 (5, 14, 24, 28) 0.33
Total FACT-G 84 (39, 74, 93, 107) 81 (38, 70, 96, 107) 0.72
1The sample median (minimum, 25th percentile, 75th percentile, maximum)
is given.
2P-values result from Wilcoxon rank sum test comparing NSS to RN.
Table 5 Baseline Reponses to RCC-specific QoL Questions






I urinate more frequently than usual 0.90
Not at all & A little bit 41 (59%) 40 (56%)
Somewhat 16 (23%) 19 (26%)
Quite a bit & Very much 13 (19%) 13 (18%)
I have sudden strong urges to urinate 0.28
Not at all & A little bit 41 (59%) 47 (65%)
Somewhat 16 (23%) 9 (13%)
Quite a bit & Very much 13 (19%) 16 (22%)
Problems with urinating limit my
activities
1.00
Not at all & A little bit 62 (89%) 63 (89%)
Somewhat 6 (9%) 7 (10%)
Quite a bit & Very much 2 (3%) 1 (1%)
I have been vomiting 0.24
Not at all & A little bit 66 (94%) 70 (97%)
Somewhat 1 (1%) 2 (3%)
Quite a bit & Very much 3 (4%) 0 (0%)
Injuries (cuts, scrapes, bruises) heal slowly 0.83
Not at all & A little bit 58 (83%) 62 (86%)
Somewhat 7 (10%) 6 (8%)
Quite a bit & Very much 5 (7%) 4 (6%)
I experience significant pain in certain
areas of my body
0.42
Not at all & A little bit 41 (59%) 50 (69%)
Somewhat 9 (13%) 6 (8%)
Quite a bit & Very much 20 (29%) 16 (22%)
Problems with pain limit my activities 0.18
Not at all & A little bit 49 (70%) 54 (75%)
Somewhat 7 (10%) 11 (15%)
Quite a bit & Very much 14 (20%) 7 (10%)
I am satisfied with my present comfort
level
0.54
Not at all & A little bit 21 (30%) 20 (28%)
Somewhat 21 (30%) 17 (24%)
Quite a bit & Very much 28 (40%) 35 (49%)
I am forgetful 0.27
Not at all & A little bit 49 (70%) 41 (57%)
Somewhat 14 (20%) 19 (26%)
Quite a bit & Very much 7 (10%) 12 (17%)
1N (%) is given.
2P-values result from Fisher’s Exact test comparing association of Not at all & A
little bit, Somewhat, Quite a bit & Very much (3 groups) to Partial and Radical
surgical groups.
3Information was not available for one patient in the NSS group and 1 to a
maximum of 2 patients in the RN group.
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rule out the role of chance.
Finally, given the differences we noted in pathologic
features between the RN and NSS groups (particularly
pT stage), in an exploratory fashion we repeated our
comparisons limiting to only those patients with pT1
disease (NSS = 59 pts, RN = 39 pts) and present these
data in Tables 6, 7 and 8. While many of the results for
the SF-36 were unchanged in this subgroup analysis, the
evidence of higher scores at baseline for NSS on the
Role Physical (100 vs. 25; p = 0.08) and Vitality (60 vs.
50; p = 0.49) domains strengthened slightly (Table 6).
The results for the standard FACT-G (i.e. very similar
median scores for NSS and RN across all domains)
remained unchanged in subset of patients with pT1 dis-
ease (Table 7). The slight differences between NSS and
RN with regard to “I experience significant pain” and
“problems with pain limits my activities” that we noted
for the entire cohort were mitigated in the subset of pT1
patients (26% vs. 26%; p0.74 and 17% vs. 13% p = 0.65;
respectively; Table 8).
Discussion
The number of patients living for long periods of time
following surgical excision of a clinically localized RCC
has increased over the past three decades. As such, is-
sues of survivorship have moved closer to the forefront
of research efforts. Related to this, studies depicting
similar oncological and QoL outcomes for NSS and RN
have been used to underscore the importance of the
adoption of NSS in eligible patients with RCC [2].
The demonstrated value of NSS notwithstanding,
what has been lacking in the discussion to this point
has been a direct comparison of baseline characteris-
tics (including QoL measures) between patients electing
to undergo NSS versus RN for localized RCC. That is,
to date there are no published data to suggest that
RN and NSS patients have similar QoL status at base-
line (an assumption that is inherent in the existing
studies that have compared QoL outcomes between
the two groups). If baseline differences do exist, this
Table 6 Patient Baseline SF-36 Index scores by treatment
type (NSS vs. RN) in patients with pT1 RCC
Variable NSS1 (N = 59) RN1 (N = 39) p-value2
Physical
Functioning
75 (5, 37.5, 95, 100) 68 (0, 50, 85, 100) 0.51
Bodily Pain 62 (0, 41, 86, 100) 51 (20, 31, 74, 100) 0.35
General Health 72 (10, 50, 82, 100) 77 (6.3, 37, 90, 100) 0.91
Mental Health 72 (35, 60, 84, 100) 80 (24, 64, 96, 100) 0.059
Role Emotional 67 (0, 0, 100, 100) 100 (0, 0, 100, 100) 0.64
Role Physical 100 (0, 0, 100, 100) 25 (0, 0, 100, 100) 0.081
Social
Functioning
75 (0, 56.3, 100, 100) 75 (12.5, 37.5, 100, 100) 0.68
Vitality 60 (0, 35, 70, 100) 50 (5, 30, 70, 100) 0.49
1The sample median (minimum, 25th percentile, 75th percentile, maximum)
is given.
2P-values result from Wilcoxon rank sum test comparing NSS to RN.
Table 8 Baseline Reponses to RCC-specific Questions
Added to the FACT-G by treatment type (NSS vs. RN) in






I urinate more frequently than usual 0.44
Not at all & A little bit 35 (60%) 20 (53%)
Somewhat 13 (22%) 13 (34%)
Quite a bit & Very much 10 (17%) 5 (13%)
I have sudden strong urges to urinate 0.87
Not at all & A little bit 35 (60%) 24 (63%)
Somewhat 12 (21%) 6 (16%)
Quite a bit & Very much 11 (19%) 8 (21%)
Problems with urinating limit my
activities
0.68
Not at all & A little bit 52 (90%) 33 (89%)
Somewhat 6 (10%) 3 (8%)
Quite a bit & Very much 0 (0%) 1 (3%)
I have been vomiting 0.49
Not at all & A little bit 55 (95%) 36 (95%)
Somewhat 1 (2%) 2 (5%)
Quite a bit & Very much 2 (3%) 0 (0%)
Injuries (cuts, scrapes, bruises) heal slowly 0.77
Not at all & A little bit 49 (84%) 30 (79%)
Somewhat 6 (10%) 5 (13%)
Quite a bit & Very much 3 (5%) 3 (8%)
I experience significant pain in certain
areas of my body
0.74
Not at all & A little bit 35 (60%) 25 (66%)
Somewhat 8 (14%) 3 (8%)
Quite a bit & Very much 15 (26%) 10 (26%)
Problems with pain limit my activities 0.65
Not at all & A little bit 41 (71%) 26 (68%)
Somewhat 7 (12%) 7 (18%)
Quite a bit & Very much 10 (17%) 5 (13%)
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up QoL data. By example, if RN patients have higher
baseline QoL on average compared to NSS patients,
then a study reporting similar QoL metrics at follow-
up for these two groups would mask the fact that the
surgery had a greater negative impact on the RN ver-
sus the NSS group.
To address the gap in our knowledge regarding base-
line comparisons of between NSS and RN patients, we
used data from our prospective Registry to report for
the first time on simultaneous comparisons of baseline
demographics, pathologic features, performance scores,
comorbidities, symptoms at presentation and responses to
QoL surveys between NSS and RN patients. Specifically,
we observed RN patients to have more aggressive tumor
pathology and a slightly lower BMI compared to NSS pa-
tients. While we noted no differences in overall perform-
ance scores between the two groups, we did observe that
RN patients were more likely to be classified in the highest
Charlson score categories (i.e. > = 3) and report a variety
of symptoms at presentation than the NSS patients. From
a QoL perspective, we report evidence of differencesTable 7 Patient Baseline FACT-G Index scores by
treatment type (NSS vs. RN) in patients with pT1 RCC
Variable NSS1 (N = 59) RN1 (N = 39) p-value2
Physical Well Being 26 (0, 20, 27, 28) 24 (4.7, 19, 27, 28) 0.39
Emotional Well
Being
17 (8, 15, 19, 24) 18 (10, 14, 20, 24) 0.35
Social/Family Well
Being
24 (0, 20, 27, 28) 24 (10, 19, 26, 28) 0.73
Functional Well
Being
21 (2.3, 16, 24, 28) 18 (5, 14, 24, 28) 0.29
Total FACT-G 83 (39, 74, 93, 104) 80 (37.7, 69, 94, 105) 0.48
1The sample median (minimum, 25th percentile, 75th percentile, maximum)
is given.
2P-values result from Wilcoxon rank sum test comparing Partial to Radical.
I am satisfied with my present comfort
level
1.00
Not at all & A little bit 18 (31%) 12 (32%)
Somewhat 17 (29%) 11 (29%)
Quite a bit & Very much 23 (40%) 15 (39%)
I am forgetful 0.093
Not at all & A little bit 43 (74%) 20 (53%)
Somewhat 10 (17%) 11 (29%)
Quite a bit & Very much 5 (9%) 7 (18%)
1N (%) is given.
1Additional Fact-G questions were not responded to in n = 1 NSS and n = 1
RN patient.
2P-values result from Fisher’s Exact test comparing association of ‘Not at All
& A Little Bit’, ‘Somewhat’, ‘Quite a Bit & Very Much’ (3 groups) to NSS and
RN groups.
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36 and a set of amended questions to the FACT-G that
were developed from our previous focus group of RCC pa-
tients. [4] Interestingly, we report no evidence of differ-
ences between the two groups on the FACT-G. When we
analyzed only the subset of RCC patients in each surgical
group with pT1 disease (i.e. the group most likely to re-
ceive NSS), we observed emerging evidence of better
baseline scores for the NSS compared to RN patients on
the Role Physical and Vitality domains of the SF-36. In
addition, we also observed significantly lower baseline
scores on the Mental Health domain in the NSS group
compared to the RN group. In contrast, scores on the
standard FACT-G remained similar and the differences
we noted on the set of amended RCC-specific questions
were attenuated.
This contrast between the results we obtained on the
SF-36 and the FACT-G warrants further discussion, with
a likely explanation centering on the nature of the sur-
veys. That is, the SF-36 is designed to measure general
well-being, while the FACT-G is more disease-specific
(to RCC, in our case). For example, the SF-36 Mental
Health domain is intended to evaluate the general emo-
tional state of the individual (high score implies feeling
peaceful, happy, calm) unrelated to any disease state. By
comparison, the Emotional Well-being domain of the
FACT-G is intended to assess the emotional state of the
individual in terms of their cancer (e.g., “I am satisfied
with how I am coping with my illness”). With this in
mind, a logical interpretation of our results is that the
QoL metrics that are important for patients with RCC,
and those that could be modulated by the type of sur-
gery are not disease specific. Further supporting this no-
tion is our own previous observation that RCC patients
do not express a high level of concern regarding their
cancer following surgical excision of the tumor [4]. In-
deed, attitudes expressed in the focus groups for our
previous study indicated a low level of concern regarding
the risk of cancer recurrence following surgery. Therefore,
in contrast to patients with breast and prostate cancer
who often express a high level of anxiety about their risk
of recurrence following surgical treatment, patients with
RCC are comparatively less focused on cancer-related is-
sues due in part to a feeling of being “cured”. This is con-
sistent with our observation in the current study that the
disparities in QoL measures between NSS and RN are lim-
ited to only non-disease specific metrics measured by the
more general SF-36.
In our review of the literature, we identified seven
teams of investigators who prior to 2012 reported on
QoL metrics in RCC patients post surgical intervention.
Of these, three provided analysis directly comparing
QoL outcomes between NSS and RN patients. Interest-
ingly, while Poulakis et al. [5] concluded that there wasno difference in follow-up QoL measures between the
NSS and RN groups, both Clark and Ficarra present data
suggesting that QoL outcomes may be better among the
NSS group [6,8]. The strengths of these two studies
aside, it is worth noting that neither team conducted
prospective enrollment of patients, the time to follow-up
QoL measures varied considerably across participants in
each study and most importantly, neither provided dir-
ect comparisons of preexisting comorbidities, symptoms
at presentation or baseline measures of QoL between
the RN and NSS groups. As such, given that the absence
of a baseline for each group, it is difficult to draw mean-
ingful conclusions regarding the true effect of NSS and
RN on RCC patient QoL.
More recently, Parker et al. [10]. advanced the field
with their publication of data from the most comprehen-
sive, prospective assessment to date of QoL outcomes in
patients undergoing surgery for localized RCC. Briefly,
the authors report comparisons of QoL outcomes data
on 172 patients undergoing surgery for localized RCC by
one of four surgical modalities (laparoscopic partial = 20,
laparoscopic radical =55, open partial = 72, and open
radical =25). Of interest to our findings, the authors re-
port that those patients undergoing RN reported lower
global scores on the CARES-SF survey at all follow-up
time points (indicating better cancer-specific QoL) than
patients who underwent NSS. While these results have
advanced our overall understanding of the impact of
RCC surgery on patient QoL, there are key aspects of
this study that should be considered before drawing final
conclusions. First and foremost, while the authors did
collect baseline QoL data they do not present these data
for review and only state that they observed “no signifi-
cant differences in baseline scores”. Given that the focus
of the paper was on four surgical modalities, without a
display of the baseline data it is difficult to know if spe-
cific differences between the RN and NSS subgroups
may have existed but were not statistically significant
due to a global statistical test across four patient sub-
groups (instead of just NSS vs. RN). Moreover, in Figure
B of their manuscript they display a graph showing not-
able differences in QoL scores between RN and NSS
groups at the first 3 week follow-up time point, thus
underscoring the question of how comparable these two
groups were with respect to QoL metrics at baseline. In
addition to the absence of a presentation of the baseline
QoL scores, Parker et al. do not provide any data on the
relevant issues of performance status, comorbidity or
symptoms at presentation for the surgical groups at
baseline. Related to this, our findings regarding Charlson
Score suggest that the RN patients are more likely to
have higher Charlson scores (i.e. 3 or greater) at baseline
than the NSS group. Similarly, we assessed patient
symptoms at presentation and report that RN patients
Arnold et al. BMC Urology 2013, 13:52 Page 8 of 9
http://www.biomedcentral.com/1471-2490/13/52had higher incidence of symptoms at presentation than
NSS patients. As such, our data support that both of
these factors (increased comorbid disease and greater
symptoms at baseline) can and should be factored in to
analysis of QoL outcomes between these two surgical
groups.
There are specific limitations of the present study to
be mindful of when interpreting our results, chief among
these being our limited sample size. More specifically,
we must be mindful that due to the smaller sample size
in this investigation, our power to detect potentially
meaningful clinical differences is limited. As such, we
would advocate against the dismissal of a difference in
scores that is notable but does not have an adequate p-
value to achieve conventional statistical significance,
since this could simply be due to the limited power of
this pilot study. The limited power in certain cases not-
withstanding, ours is the first study to directly compare
baseline metrics between NSS and RN patients and as
such, our results are informative to the larger discussion
of the need to include baseline data when comparing
QoL outcomes between these two patient groups. Re-
lated to this, our sample is drawn from a patient popula-
tion at a tertiary referral center, and therefore may lack
generalizability to the general population of RCC pa-
tients. As such, validation of our results in a larger, more
diverse patient group is needed. Specifically, a prospect-
ive evaluation of health-related QoL outcomes that in-
cludes baseline measures with larger numbers in both
surgical groups would serve as a validation study in this
population. Related to this, we advocate for efforts to
centralize the collection of QoL data in a more systematic
way across institutions like ours that maintain prospective
RCC registries. Such efforts would greatly enhance large-
scale validation opportunities. Finally, we did not use a
validated survey for measuring RCC-specific QoL because
there are currently no validated tools for measuring RCC-
specific QoL. We attempt to address this disparity by util-
izing a modified, renal specific version of the FACT-G that
included questions derived from our previously published
focus group of RCC patients [4]. The benefits of this ap-
proach aside, future investigations of RCC-related QoL
can and should address this need for a validated measure
as this will be of great importance in an era where issues
of survivorship have moved closer to the forefront of re-
search efforts.
Conclusions
We report evidence of differences in key clinical and
pathological metrics at baseline between patients under-
going NSS and RN. We also report for the first time that
RN patients indicate better mental health status on the
SF-36 than NSS patients at baseline. The remainder of
the differences we noted on the SF-36 domains achievedonly borderline statistical significance and we report no
evidence of differences on the standard FACT-G. That be-
ing said, our data support the need for consideration of
baseline status when conducting comparisons of follow-up
QoL measures between these two surgical groups. More
importantly, our report underscores the need for the de-
velopment of better, more-kidney-specific QoL assessment
tools in order to accurately reflect any post-operative
change in QoL as it relates to surgical treatment.
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